Atopic Dermatitis, Sleep, and the COVID-19 Pandemic.

IF 1 Q4 CLINICAL NEUROLOGY

Sleep Science Pub Date : 2024-05-29 eCollection Date: 2025-03-01 DOI:10.1055/s-0044-1787275

Priscila Vernizi Roth, Renata Drizlionoks, Rafaela Cachiolo Antunes, Ana Chrystina Souza Crippa, Mariana Aparecida Pasa Morgan, Vânia Oliveira de Carvalho

{"title":"Atopic Dermatitis, Sleep, and the COVID-19 Pandemic.","authors":"Priscila Vernizi Roth, Renata Drizlionoks, Rafaela Cachiolo Antunes, Ana Chrystina Souza Crippa, Mariana Aparecida Pasa Morgan, Vânia Oliveira de Carvalho","doi":"10.1055/s-0044-1787275","DOIUrl":null,"url":null,"abstract":"Objective To investigate sleep disorders among children with atopic dermatitis (AD), before and during the coronavirus disease 2019 (COVID-19) pandemic. Materials and Methods The present longitudinal, prospective study included 26 patients with AD, and the Sleep Disturbance Scale for Children (SDSC) questionnaire and questions about sleep hygiene were used. The severity of AD was determined by the Patient-Oriented Eczema Measure (POEM). The first evaluation was conducted before the pandemic (in 2019) and the second, during the pandemic, from September to December 2020. Results Sleep disorder was present in 17 (65.38%) patients in the 1st evaluation, and in 11 (42.30%) in the 2nd ( p = 0.04). In the 1st evaluation, disorders of initiating and maintaining sleep (DIMSs) were more frequent in patients with moderate-to-severe AD (83.33%). During the pandemic, 6 patients (23.07%) reported improvement in sleep quality. Conclusion Sleep quality was negatively influenced by the severity of AD. During the COVID-19 pandemic, there was improvement in sleep quality, despite the absence of changes in disease severity.","PeriodicalId":21848,"journal":{"name":"Sleep Science","volume":"18 1","pages":"e97-e103"},"PeriodicalIF":1.0000,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12020565/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sleep Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0044-1787275","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective To investigate sleep disorders among children with atopic dermatitis (AD), before and during the coronavirus disease 2019 (COVID-19) pandemic. Materials and Methods The present longitudinal, prospective study included 26 patients with AD, and the Sleep Disturbance Scale for Children (SDSC) questionnaire and questions about sleep hygiene were used. The severity of AD was determined by the Patient-Oriented Eczema Measure (POEM). The first evaluation was conducted before the pandemic (in 2019) and the second, during the pandemic, from September to December 2020. Results Sleep disorder was present in 17 (65.38%) patients in the 1st evaluation, and in 11 (42.30%) in the 2nd ( p = 0.04). In the 1st evaluation, disorders of initiating and maintaining sleep (DIMSs) were more frequent in patients with moderate-to-severe AD (83.33%). During the pandemic, 6 patients (23.07%) reported improvement in sleep quality. Conclusion Sleep quality was negatively influenced by the severity of AD. During the COVID-19 pandemic, there was improvement in sleep quality, despite the absence of changes in disease severity.

查看原文本刊更多论文

特应性皮炎、睡眠和COVID-19大流行。

目的了解2019冠状病毒病（COVID-19）大流行前和期间特应性皮炎（AD）患儿的睡眠障碍情况。材料与方法对26例AD患者进行纵向、前瞻性研究，采用儿童睡眠障碍量表（SDSC）和睡眠卫生问卷。AD的严重程度由患者导向湿疹测量（POEM）来确定。第一次评估是在大流行之前（2019年）进行的，第二次评估是在大流行期间（2020年9月至12月）进行的。结果第一次评估有17例（65.38%）存在睡眠障碍，第二次评估有11例（42.30%）存在睡眠障碍（p = 0.04）。在第一次评估中，启动和维持睡眠障碍（DIMSs）在中重度AD患者中更为常见（83.33%）。大流行期间，6名患者（23.07%）报告睡眠质量有所改善。结论AD严重程度对睡眠质量有负向影响。在COVID-19大流行期间，尽管疾病严重程度没有变化，但睡眠质量有所改善。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊